Aleksandra Pastrak - Transition Therapeutics Insider

TTH -- Canada Stock  

CAD 1.93  0.00  0.00%

Dr. Aleksandra Pastrak is Vice President Clinical Development and Medical Officer of Transition Therapeutics Inc. Dr. Pastrak was with Transition since 1999 and served as VP Research since 2005 until she was appointed VP Clinical Development in 2011. With her expertise in medicine and pharmacology she has made an invaluable contribution to the development of our clinical programs for various therapeutic products
Age: 45  VP Since 2011  Ph.D    
Pastrak holds an MD from the School of Medicine at the University of Belgrade and M.Sc. and Ph.D. degrees in Clinical Pharmacology from the University of Toronto.

Management Efficiency

The company has return on total asset (ROA) of (34.83) % which means that it has lost $34.83 on every $100 spent on asset. This is way below average.

Similar Executives

Found 1 records

VP Since

Jake LawrenceThe Bank of Nova Scotia

Entity Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. Transition Therapeutics (TTH) is traded on Toronto Stock Exchange in Canada. It is located in Toronto, ON MG L and employs 18 people.

Transition Therapeutics Leadership Team

Christopher Henley, Independent Director
Gary Pace, Independent Director
Carl Damiani, Pres and COO
Bruce Connop, VP of Non-Clinical and Pharmaceutical Devel.
Louis Alexopoulos, Secretary
Nicole Rusaw, CFO
Aleksandra Pastrak, VP of Clinical Devel. and Medical Officer
Paul Baehr, Independent Director
Michael Ashton, Lead Independent Director
Tony Cruz, Chairman and CEO

Stock Performance Indicators

Did you try this?

Run Portfolio Diagnostics Now

Portfolio Diagnostics

Use generated alerts and portfolio events aggregator to diagnose current holdings
All  Next Launch Portfolio Diagnostics
Currently Active Assets on Macroaxis
Purchased over 20 shares of
a day ago
Traded for 106.27
Purchased over 200 shares of
a day ago
Traded for 10.56
Purchased over 70 shares of
a day ago
Traded for 39.4
Purchased few shares of
a day ago
Traded for 1184.91
Purchased over 40 shares of
a day ago
Traded for 69.22
Also please take a look at World Market Map. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.